Related Experiment Video
Updated: Sep 26, 2025

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
624
Optimizing 90Y Particle Density Improves Outcomes After Radioembolization
Aaron W P Maxwell1, Humberto G Mendoza2, Matthew J Sellitti3
1Department of Diagnostic Imaging, The Warren Alpert Medical School, Brown University, Providence, RI, USA.
Cardiovascular and Interventional Radiology
|April 23, 2022
Summary
Optimizing particle density in radioembolization improves treatment outcomes. Tailoring particle delivery based on tumor vascularity enhances local progression-free survival and overall survival, outperforming conventional dosimetry.
Area of Science:
- Interventional Radiology
- Nuclear Medicine
- Oncology
Background:
- Lobar radioembolization uses microspheres to deliver radiation directly to liver tumors.
- Particle density influences radiation dose distribution and treatment efficacy.
- Understanding the relationship between particle density, dose, and outcomes is crucial for optimizing therapy.
Purpose of the Study:
- To investigate the impact of particle density on dose distribution and patient outcomes in lobar radioembolization.
- To compare outcomes between glass and resin microspheres based on particle density.
Main Methods:
- Retrospective study of 114 matched patients treated with glass versus resin microspheres.
- Analysis of tumor and liver particle density (particles/cm³), and radiation dose (Gy).
- Utilized 99mTc-MAA SPECT/CT and 90Y bremsstrahlung SPECT/CT for dose assessment and microdosimetry simulations to calculate cold spot doses.
Main Results:
- Increased particle delivery led to more uniform 90Y doses, reducing differences between tumor and liver doses.
- Optimal particle density, tailored to tumor vascularity (hypervascular vs. less vascular), improved local progression-free survival (LPFS).
- Optimized particle density significantly improved overall survival (11.5 vs. 6.8 months) and microdosimetry predictions compared to conventional dosimetry.
Conclusions:
- Particle density can be adjusted based on tumor vascularity to maximize tumor dose and minimize liver dose.
- Optimizing particle density is a key factor in improving LPFS and overall survival in radioembolization.
- Microdosimetry offers superior prediction of treatment outcomes compared to conventional dosimetry.

